Mechanism: Selective Vulnerability of Dopaminergic Neurons in Parkinson's Disease

SUMMARY

# Mechanism: Selective Vulnerability of Dopaminergic Neurons in Parkinson's Disease ## Background and Rationale The selective vulnerability of dopaminergic neurons in the substantia nigra pars compacta (SNc) represents one of the most intriguing and clinically relevant questions in Parkinson's disease research. While the SNc experiences profound neuronal loss (up to 70-80% by symptom onset), adjacent dopaminergic neurons in the ventral tegmental area (VTA) remain relatively preserved throughout

METHODOLOGY NOTES

**Phase 1: Human Tissue Acquisition and Preparation (Months 1-3)** • Obtain post-mortem brain tissue from n=30 Parkinson's disease patients and n=30 age-matched controls through brain banks • Collect detailed clinical histories including disease duration, Hoehn-Yahr staging, and medication history • Perform systematic sampling of SNc and VTA regions using stereological methods • Process tissue for multiple analyses: fresh-frozen for RNA/protein extraction, fixed for immunohistochemistry • Validate tissue quality using RIN scores >6.0 for RNA and post-mortem interval <12 hours **Phase 2: Morphological and Neuronal Loss Assessment (Months 2-4)** • Conduct unbiased stereological counting of tyrosine hydroxylase-positive neurons in SNc and VTA • Perform Nissl staining to assess total neuronal populations • Calculate neuronal density and volume measurements using systematic random sampling • Document presence of Lewy bodies and neuromelanin pigmentation patterns • Quantify microglia activa